Charity Target Ovarian Cancer is leading the way in addressing the ‘unacceptable’ variation in the diagnosis of ovarian cancer – which is currently failing women who are diagnosed too late. Research co-funded by Target Ovarian Cancer showed that the proportion of women diagnosed at an early stage (I or II) varies from 22 per cent […]
Read More… from Earlier diagnosis of ovarian cancer is possible
Prostate cancer: “liquid biopsies” allow non-invasive diagnosis of metastatic cancers: In future, newly identified biomarkers could be used alongside imaging techniques for the non-invasive diagnosis of patients with advanced prostate cancer. A research team from the Medical University of Vienna and the Ludwig Boltzmann Institute Applied Diagnostics developed epigenetic biomarkers for the detection of circulating […]
COVID-19: cancer diagnosis and care: Covid-19 may have changed the way people have been diagnosed with cancer and how they receive care – new study to investigate by Natasha Meredith of the University of Surrey An important new study from the University of Surrey and UCL is set to investigate how rapid changes in cancer […]
Late stage cancers increase as Covid fall-out bites: The impact of delays in cancer diagnostic services caused by the COVID-19 pandemic are emerging now with an increase in patients seeking treatment for later stage conditions. Breast cancer diagnostic services in the UK can detect over 20,000 cancers per year in the UK, saving thousands of […]
Read More… from Late stage cancers increase as Covid fall-out bites